Fujifilm said Monday it would buy a US vaccine maker as the Japanese firm boosts its supply of an experimental Ebola drug to help stem the spread of the virus. The deal would see Fujifilm take a 49 percent stake in Kalon Biotherapeutics, with plans to buy the whole company "in the future", the company said, without supplying financial details. Japan's leading Nikkei business daily said the acquisition would be worth several billion yen (tens of millions of dollars). Kalon, established in 2011 by the State of Texas and Texas A&M University as a contract maker of biopharmaceutical products, can safely handle and produce vaccines against deadly pathogens, including anthrax, Fujifilm said, as it looks to further tap the health sector.
via Health News Headlines - Yahoo News
Read More Here.. 
Lake forest health and fitness http://ift.tt/1tvIXGW
No comments:
Post a Comment